Polygenic profiles define aspects of clinical heterogeneity in ADHD
Andrew J. Schork(University of Copenhagen), Thomas Werge(Cardiff University), Søren Dalsgaard(Lundbeck Foundation), Ole Mors(Aarhus University), Preben Bo Mortensen(Aarhus University), Daniel H. Geschwind(University of California, Los Angeles), Marianne Giørtz Pedersen(Aarhus University), Anders D. Børglum(Aarhus University), Rebecca L. Walker(Broad Institute), Dorte Helenius(Mental Health Services), Merete Nordentoft(University of Copenhagen), Robert Loughnan(J. Craig Venter Institute), Joel Mefford(University of California, Los Angeles), Esben Agerbo(Aarhus University), Jesper R. Gådin(Mental Health Services), Terry L. Jernigan(Cognitive Research (United States)), Noah Zaitlen(University of California, Los Angeles), Sonja LaBianca(Mental Health Services), Isabell Brickell, Morten Dybdahl Krebs(Sankt Hans Hospital), Morteza Vaez(Amager Hospital), Vivek Appadurai(Mental Health Services), David M. Hougaard(Statens Serum Institut), Andrés Ingason(deCODE Genetics (Iceland)), Kenneth S. Kendler(Virginia Commonwealth University), Andy Dahl, Clare E. Palmer(NHS Digital)
Cited by 1
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
The Basics of Brain Development
|Neuropsychology Review|2010|2k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k